{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T10:31:57Z","timestamp":1790937117269,"version":"4.1.0"},"reference-count":27,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T00:00:00Z","timestamp":1708560000000},"content-version":"unspecified","delay-in-days":21,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006578","name":"Chi Mei Medical Center","doi-asserted-by":"publisher","award":["CMFHR112102"],"award-info":[{"award-number":["CMFHR112102"]}],"id":[{"id":"10.13039\/501100006578","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Resp Res"],"accepted":{"date-parts":[[2024,2,2]]},"published-print":{"date-parts":[[2024,2]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Chronic airway diseases have been associated with an increased risk of tuberculosis (TB); however, data in patients with bronchiectasis is limited. Statins have been shown to exhibit anti-inflammatory effects by modulating the inflammatory response. This study investigated whether statin treatment could reduce the risk of TB in patients with bronchiectasis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We conducted a retrospective cohort study using a nationwide population database of patients with bronchiectasis who did or did not receive statin treatment. The defined daily dose (DDD) of statin, current or past statin user and statin exposure time were measured for the impact of statin use. The primary outcome was the incidence of new-onset TB. Considering of potential immortal time bias due to stain exposure time, Cox regression models with time-dependent covariates were employed to estimate HRs with 95% CIs for TB incidence among patients with bronchiectasis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Patients with bronchiectasis receiving statin treatment had a decreased risk of TB. After adjusting for age, sex, income, comorbidities and Charlson Comorbidity Index, statin users had a 0.59-fold lower risk of TB incidence compared with non-statin users (95%\u2009CI 0.40 to 0.88; p=0.0087). Additionally, compared with non-statin users, statin treatment was a protective factor against TB in users with a cumulative DDD greater than 180 per year, with an HR of 0.32 (95% CI 0.12 to 0.87; p=0.0255).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Statin treatment demonstrated a dose-dependent protective effect and was associated with a reduced risk of TB in patients with bronchiectasis. These findings suggest that statins may play a role in lowering TB risk by modulating airway inflammation in this patient population.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjresp-2023-002077","type":"journal-article","created":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T12:31:06Z","timestamp":1708605066000},"page":"e002077","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Association between statin use and tuberculosis risk in patients with bronchiectasis: a retrospective population-based cohort study in Taiwan"],"prefix":"10.1136","volume":"11","author":[{"given":"Kuang-Ming","family":"Liao","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Chi Mei Medical Center Chiali Branch, Tainan, Taiwan"},{"name":"Department of Nursing, Min-Hwei Junior College of Health Care Management, Tainan, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Shu","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, New Taipei Municipal Tu Cheng Hospital, New Taipei City, Taiwan"},{"name":"Department of Thoracic Medicine, Chang Gung Memorial Hospital, Chang Gung University, School of Medicine, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Cih","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Medical Research, Chi Mei Medical Center, Tainan, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0311-5148","authenticated-orcid":false,"given":"Chin-Chung","family":"Shu","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan"},{"name":"National Taiwan University, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5925-8477","authenticated-orcid":false,"given":"Chung-Han","family":"Ho","sequence":"additional","affiliation":[{"name":"Department of Medical Research, Chi Mei Medical Center, Tainan, Taiwan"},{"name":"Department of Information Management, Southern Taiwan University of Science and Technology, Tainan, Taiwan"},{"name":"Cancer Center, Taipei Municipal Wanfang Hospital, Taipei Medical University, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,2,22]]},"reference":[{"key":"2025083110104469000_11.1.e002077.1","unstructured":"World Health Organization . Global tuberculosis report 2022. 2022. Available: https:\/\/www.who.int\/teams\/global-tuberculosis-programme\/tb-reports\/global-tuberculosis-report-2022 [Accessed 07 Aug 2023]."},{"key":"2025083110104469000_11.1.e002077.2","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0077-2017","article-title":"Tuberculosis and lung damage: from epidemiology to pathophysiology","volume":"27","author":"Ravimohan","year":"2018","journal-title":"Eur Respir Rev"},{"key":"2025083110104469000_11.1.e002077.3","doi-asserted-by":"crossref","first-page":"4542","DOI":"10.3390\/jcm10194542","article-title":"On behalf of the KMBARC. clinical characteristics of patients with post-tuberculosis bronchiectasis: findings from the KMBARC registry","volume":"10","author":"Choi","year":"2021","journal-title":"JCM"},{"key":"2025083110104469000_11.1.e002077.4","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1111\/resp.12832","article-title":"Aetiology of bronchiectasis in adults: a systemic literature review","volume":"21","author":"Gao","year":"2016","journal-title":"Respirology"},{"key":"2025083110104469000_11.1.e002077.5","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.55.3.198"},{"key":"2025083110104469000_11.1.e002077.6","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1148\/rg.2015140214","article-title":"Bronchiectasis: mechanisms and imaging clues of associated common and uncommon diseases","volume":"35","author":"Milliron","year":"2015","journal-title":"Radiographics"},{"key":"2025083110104469000_11.1.e002077.7","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1093\/trstmh\/trab122","article-title":"Risk for development of active tuberculosis in patients with chronic airway disease-a systematic review of evidence","volume":"116","author":"Hamada","year":"2022","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"2025083110104469000_11.1.e002077.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2010.02.043"},{"key":"2025083110104469000_11.1.e002077.9","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200810-1584OC"},{"key":"2025083110104469000_11.1.e002077.10","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.chest.2017.05.017","article-title":"A randomized controlled trial of atorvastatin in patients with bronchiectasis infected with pseudomonas aeruginosa: a proof of concept study","volume":"152","author":"Bedi","year":"2017","journal-title":"Chest"},{"key":"2025083110104469000_11.1.e002077.11","unstructured":"Powell TM , Bagnell ME . Your \u201csurvival\u201d guide to using time-dependent covariates. Proc SAS Glob Forum; 2012:22\u20135"},{"key":"2025083110104469000_11.1.e002077.12","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1093\/infdis\/jiz517","article-title":"Adjunctive host-directed therapy with statins improves tuberculosis-related outcomes in mice","volume":"221","author":"Dutta","year":"2020","journal-title":"J Infect Dis"},{"key":"2025083110104469000_11.1.e002077.13","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)05917-0"},{"key":"2025083110104469000_11.1.e002077.14","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.81.6.963"},{"key":"2025083110104469000_11.1.e002077.15","doi-asserted-by":"crossref","DOI":"10.3390\/jcm7120517","article-title":"Mucolytic agents and statins use is associated with a lower risk of acute exacerbations in patients with bronchiectasis-chronic obstructive pulmonary disease overlap","volume":"7","author":"Su","year":"2018","journal-title":"J Clin Med"},{"key":"2025083110104469000_11.1.e002077.16","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S2213-2600(14)70050-5","article-title":"Atorvastatin as a stable treatment in bronchiectasis: a randomized controlled trial","volume":"2","author":"Mandal","year":"2014","journal-title":"Lancet Respir Med"},{"key":"2025083110104469000_11.1.e002077.17","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-005-2859-y"},{"key":"2025083110104469000_11.1.e002077.18","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9150(00)00417-2"},{"key":"2025083110104469000_11.1.e002077.19","doi-asserted-by":"publisher","DOI":"10.1080\/08923970902806505"},{"key":"2025083110104469000_11.1.e002077.20","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jit550"},{"key":"2025083110104469000_11.1.e002077.21","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01826-13"},{"key":"2025083110104469000_11.1.e002077.22","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkw014"},{"key":"2025083110104469000_11.1.e002077.23","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dku166"},{"key":"2025083110104469000_11.1.e002077.24","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.13.0854"},{"key":"2025083110104469000_11.1.e002077.25","doi-asserted-by":"crossref","first-page":"11369","DOI":"10.3390\/ijms160511369","article-title":"Statin, calcium channel blocker and beta blocker therapy may decrease the incidence of tuberculosis infection in elderly Taiwanese patients with type 2 diabetes","volume":"16","author":"Lee","year":"2015","journal-title":"Int J Mol Sci"},{"key":"2025083110104469000_11.1.e002077.26","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2015-207052"},{"key":"2025083110104469000_11.1.e002077.27","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.chest.2017.04.170","article-title":"Statin use is associated with a lower risk of TB","volume":"152","author":"Su","year":"2017","journal-title":"Chest"}],"container-title":["BMJ Open Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjresp-2023-002077","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T17:10:54Z","timestamp":1756660254000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopenrespres.bmj.com\/lookup\/doi\/10.1136\/bmjresp-2023-002077"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,2,22]]},"published-print":{"date-parts":[[2024,2]]}},"alternative-id":["10.1136\/bmjresp-2023-002077"],"URL":"https:\/\/doi.org\/10.1136\/bmjresp-2023-002077","relation":{},"ISSN":["2052-4439"],"issn-type":[{"value":"2052-4439","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2]]}}}